Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Certara, Inc. - Common Stock (NQ: CERT )

10.71 +0.16 (+1.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Certara, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Jim Cramer Says This Stock Is A 'Great Spec And I Usually Don't Say That,' And Analysts Approve
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Certara, Inc. (NASDAQ: CERT) is not bad and also not losing money. "I think it’s a great spec, and I usually don’t say that," he added. 
Via Benzinga
Expert Ratings for Certara
Over the past 3 months, 9 analysts have published their opinion on Certara (NASDAQ:CERT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Analyst Ratings for Certara
Certara (NASDAQ:CERT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
$3.9 Million Bet On This Technology Stock? 3 Stocks Insiders Are Buying
Although US stocks closed slightly higher on Thursday, there were a few notable insider trades. 
Via Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
5 Analysts Have This to Say About Certara
  Certara (NASDAQ:CERT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Certara: Q2 Earnings Insights
  Certara (NASDAQ:CERT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
What 4 Analyst Ratings Have To Say About Certara
Within the last quarter, Certara (NASDAQ:CERT) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
  
Via Benzinga
Here's Why Certara Stock Is Nosediving Friday
Certara Inc (NASDAQ: CERT) shares are trading lower by 15.40% to $17.08 Friday morning after the company announced a secondary offering of 7 million shares of common stock. What Else? 
Via Benzinga
Why Certara Shares Are Plunging Today
Certara Inc's (NASDAQ: CERT) Q4 FY21 sales increased 17% to $75.3 million, missing the consensus of $83.26 million. The increase was driven by $6.1 million in... 
Via Benzinga
Recap: Certara Q4 Earnings
Certara (NASDAQ:CERT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Certara... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Certara's Earnings Outlook
Certara (NASDAQ:CERT) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 62 companies set new 52-week lows. 
Via Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. 
Via Benzinga
Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session
Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. 
Via Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS. 
Via Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. 
Via Benzinga
Certara Earnings Preview
  Certara (NASDAQ:CERT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Certara will... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2022
Upgrades 
Via Benzinga
68 Biggest Movers From Yesterday
Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Organogenesis Holdings (NASDAQ:ORGO 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 107 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: Citigroup (NYSE:C) was the largest company by... 
Via Benzinga
54 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA) shares moved upwards by 78.87% to $38.06 during Thursday's regular session. As of 12:30 EST, this security is trading at... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.